Table 2.
Variables | Diabetes | Arthritis | Heart attack | |||
---|---|---|---|---|---|---|
| ||||||
OR | 95% CI | OR | 95% CI | OR | 95% CI | |
Age | 0.94* | [0.93, 0.96] | 0.99 | [0.98, 1.01] | 0.98 | [0.95, 1.01] |
Gender | ||||||
Female | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
Male | 0.79* | [0.66, 0.95] | 0.67* | [0.57, 0.79] | 1.38* | [1.06, 1.79] |
Marital status | ||||||
Not married | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
Widow | 1.01 | [0.77, 1.31] | 0.96 | [0.75, 1.23] | 1.54 | [0.93, 2.54] |
Married | 0.91 | [0.69, 1.21] | 0.80 | [0.62, 1.05] | 1.29 | [0.76, 2.17] |
Education (years) | ||||||
0 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
1–6 | 1.16 | [0.95, 1.40] | 0.94 | [0.79, 1.11] | 1.03 | [0.76, 1.39] |
≥7 | 1.09 | [0.85, 1.40] | 0.83 | [0.66, 1.05] | 1.31 | [0.90, 1.92] |
Study Cohort I | ||||||
MHAS | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
HEPESE | 2.20* | [1.70, 2.86] | 3.16* | [2.52, 3.96] | 1.31 | [0.87, 1.97] |
Study Cohort II | ||||||
MHAS | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
HEPESE | 3.55* | [2.76, 4.57] | 4.85* | [3.91, 6.02] | 1.58* | [1.09, 2.30] |
HEPESE | ||||||
Study Cohort I | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
Study Cohort II | 1.61* | [1.32, 1.97] | 1.54* | [1.26, 1.87] | 1.21 | [0.85, 1.71] |
MHAS | ||||||
Study Cohort I | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
Study Cohort II | 1.19 | [0.95, 1.50] | 0.64* | [0.53, 0.78] | 0.82 | [0.56, 1.19] |
Variables | Hypertension | Stroke | ||
---|---|---|---|---|
| ||||
OR | 95% CI | OR | 95% CI | |
Age | 0.97* | [0.95, 0.98] | 1.03* | [1.00, 1.06] |
Gender | ||||
Female | Ref. | Ref. | Ref. | Ref. |
Male | 0.64* | [0.55, 0.74] | 1.11 | [0.83, 1.48] |
Marital status | ||||
Not married | Ref. | Ref. | Ref. | Ref. |
Widow | 1.29* | [1.02, 1.62] | 1.10 | [0.68, 1.77] |
Married | 1.16 | [0.91, 1.49] | 1.04 | [0.63, 1.73] |
Education (years) | ||||
0 | Ref. | Ref. | Ref. | Ref. |
1–6 | 1.14 | [0.98, 1.33] | 0.78 | [0.58, 1.05] |
≥7 | 1.03 | [0.83, 1.27] | 0.65* | [0.43, 0.97] |
Study Cohort I | ||||
MHAS | Ref. | Ref. | Ref. | Ref. |
HEPESE | 1.27* | [1.03, 1.58] | 1.59* | [1.02, 2.50] |
Study Cohort II | ||||
MHAS | Ref. | Ref. | Ref. | Ref. |
HEPESE | 3.67* | [2.97, 4.53] | 2.64* | [1.77, 3.94] |
HEPESE | ||||
Study Cohort I | Ref. | Ref. | Ref. | Ref. |
Study Cohort II | 2.88* | [2.36, 3.52] | 1.65* | [1.15, 2.38] |
MHAS | ||||
Study Cohort I | Ref. | Ref. | Ref. | Ref. |
Study Cohort II | 1.26* | [1.06, 1.50] | 1.09 | [0.73, 1.64] |
Note. These models include participant characteristics, study cohort, study group, and the interaction between study cohort and study group. The adjusted odds ratios for study group are reported separately for Study Cohorts I and II. The adjusted odds ratios for study cohort are reported separately for HEPESE and MHAS. ADL = activities of daily living; OR = odds ratio; CI = confidence interval; MHAS = Mexican Health and Aging Study; HEPESE = Hispanic Established Populations for Epidemiologic Studies of the Elderly.
p < .05.